FDMT
Price
$6.81
Change
-$0.26 (-3.68%)
Updated
Sep 12, 04:59 PM (EDT)
Capitalization
318.04M
53 days until earnings call
TNGX
Price
$6.54
Change
-$0.31 (-4.53%)
Updated
Sep 12, 04:59 PM (EDT)
Capitalization
726.53M
53 days until earnings call
Interact to see
Advertisement

FDMT vs TNGX

Header iconFDMT vs TNGX Comparison
Open Charts FDMT vs TNGXBanner chart's image
4D Molecular Therapeutics
Price$6.81
Change-$0.26 (-3.68%)
Volume$1.95K
Capitalization318.04M
Tango Therapeutics
Price$6.54
Change-$0.31 (-4.53%)
Volume$84.94K
Capitalization726.53M
FDMT vs TNGX Comparison Chart in %
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. TNGX commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and TNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (FDMT: $6.81 vs. TNGX: $6.53)
Brand notoriety: FDMT and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 39% vs. TNGX: 107%
Market capitalization -- FDMT: $318.04M vs. TNGX: $726.53M
FDMT [@Biotechnology] is valued at $318.04M. TNGX’s [@Biotechnology] market capitalization is $726.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, TNGX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while TNGX’s TA Score has 4 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 4 bearish.
  • TNGX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than FDMT.

Price Growth

FDMT (@Biotechnology) experienced а -6.33% price change this week, while TNGX (@Biotechnology) price change was -5.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

FDMT is expected to report earnings on Nov 05, 2025.

TNGX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($727M) has a higher market cap than FDMT($318M). TNGX YTD gains are higher at: 111.327 vs. FDMT (22.262). TNGX has higher annual earnings (EBITDA): -154.8M vs. FDMT (-213.2M). FDMT has more cash in the bank: 293M vs. TNGX (181M). FDMT has less debt than TNGX: FDMT (23.1M) vs TNGX (35M). TNGX has higher revenues than FDMT: TNGX (24.3M) vs FDMT (33K).
FDMTTNGXFDMT / TNGX
Capitalization318M727M44%
EBITDA-213.2M-154.8M138%
Gain YTD22.262111.32720%
P/E RatioN/AN/A-
Revenue33K24.3M0%
Total Cash293M181M162%
Total Debt23.1M35M66%
TECHNICAL ANALYSIS
Technical Analysis
FDMTTNGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX25.14N/A
N/A
Morgan Stanley Inst Emerging Mkts A
JIEMX20.15N/A
N/A
JHancock Equity Income 1
TMDIX19.55N/A
N/A
AMG TimesSquare Mid Cap Growth Z
HFQRX7.17N/A
N/A
Janus Henderson Global Equity Income N
FSYRX11.19N/A
N/A
Fidelity Sustainable International Eq